In the early days of the pandemic, UC Berkeley professor Diana Bautista and her lab members found themselves suffering through the familiar symptoms of COVID-19 — sneezing, coughing, body aches. For Bautista, a neurobiologist who studies how sensory nerves detect touch, itch and pain, the experience sparked a scientific question: how exactly do viruses cause these symptoms?

Five years later, she and her team have published an answer. In a study led by doctoral student Sonali Mali and published in the November 13 issue of the journal Neuron, the researchers report that proteins from SARS-CoV-2 can directly stimulate sensory nerves, triggering sneezing, coughing and pain, according to a UC Berkeley news release.

The prevailing view among scientists had been that these symptoms arise only indirectly: infected epithelial and immune cells release inflammatory molecules, which then act on sensory neurons. The new study provides the first evidence that viral proteins themselves can directly activate those nerves, the university reported.

"This is the first evidence that viral proteins can directly activate sensory nerves to promote viral symptoms," Bautista, a professor of molecular and cell biology and a Howard Hughes Medical Institute investigator, said in the release.

The specific viral protein responsible is a protease called PLpro (papain-like protease). SARS-CoV-2 produces PLpro and another protease, Mpro, inside infected cells, where they cut the virus's long polyproteins into the individual proteins needed for replication. When the virus kills those cells, the contents — including the proteases — spill out and stimulate a subset of sensory nerves called nociceptors, which are found throughout the airways and are sensitive to noxious stimuli.

To test the effect, the researchers purified PLpro and dabbed it into the noses of mice. While water alone might trigger a single sneeze, PLpro triggered up to 30 sneezes per minute, the team found. They also showed that PLpro activated cultured sensory neurons in a dish, and that the effect depended on the protein's enzymatic activity — when they inactivated the catalytic site, the neurons did not respond.

The researchers traced the mechanism to a specific ion channel on sensory neurons called TRPA1 — the same channel that responds to chemicals in wasabi and garlic. PLpro activates TRPA1, which then triggers the release of neuropeptides that drive sneezing, coughing and pain.

The team also found that Mpro directly triggers sensory neurons, though it produces different reactions than PLpro. And they discovered that PLpro from two other coronaviruses — SARS-CoV-1 and MERS — also activated sensory neurons, suggesting the mechanism may be shared across related viruses.

Bautista noted that the findings could have implications for treatment. Since the pandemic began, numerous drugs targeting PLpro have been developed, though none have been approved for COVID-19. "We think that these protease inhibitors that people spent a lot of time and money developing could be important not just for preventing viral replication," she said. "They could also help treat symptoms like coughing, which could limit viral spread, and potentially prevent severe COVID-19 in individuals who are susceptible."

The direct activation of sensory nerves may also help explain some of the chronic symptoms associated with long COVID, including headache, shortness of breath, persistent cough, sore throat and chest pain, according to the researchers.

Bautista's lab had to overcome a surprising hurdle during the review process: convincing some reviewers that mice actually sneeze. Despite audio and video recordings, the team purchased a $75,000 plethysmograph to measure the lung spasms that accompany sneezes, confirming the reflex was similar to that in other animals. They also dyed the liquid containing PLpro blue so they could see and measure the expelled mucus.

The study opens up many new questions, Bautista said. "If just two viral proteins can have such a dramatic consequence on the nervous system, what else are viruses and other viral proteins doing?" she asked. "What happens when the neurons themselves get infected, which we know can happen? How are the neurons contributing to the antiviral response? There are many questions."

The research was funded by grants from the National Institutes of Health and the Howard Hughes Medical Institute.